title: Sequential liver-kidney transplantation.
abstract: The indications for sequential liver and kidney transplantation have not been well defined. Two categories of patients may benefit from this procedure: patients with primary renal disease associated with hepatic disorders (glomerulonephritis, tubulointerstitial nephritis, metabolic diseases, and structural diseases) and patients who develop renal failure after liver transplantation. Chronic renal failure is a frequent long-term complication after liver transplantation. End-stage renal disease develops in 2% to 10% of cases by 10 years after transplantation. Kidney transplantation appears to be a better option than dialysis for the treatment of end-stage renal disease after liver transplantation. In contrast, survival rates, after kidney transplantation are significantly lower among liver transplant patients than primary-only kidney transplant recipients. Considering the donor shortage, kidney transplantation should be cautiously considered in liver transplantation patients. New immunosuppressive drugs and protocols are needed to reduce chronic renal failure after liver transplantation.
authors.affiliation: Liver Transplantation Center, S. Giovanni Battista Hospital, Turin, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Salizzoni
authors.forename: F
authors.initials: F
authors.lastname: Gennari
authors.forename: G
authors.initials: G
authors.lastname: Liddo
authors.forename: S
authors.initials: S
authors.lastname: Mirabella
authors.forename: A
authors.initials: A
authors.lastname: Brunati
authors.forename: P
authors.initials: P
authors.lastname: Strignano
authors.forename: E
authors.initials: E
authors.lastname: Cerutti
mesh_terms: D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000601:surgery*; D016030:Kidney Transplantation / Q000379:methods*; D008107:Liver Diseases / Q000150:complications / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects*; D011183:Postoperative Complications / Q000601:surgery*; D016896:Treatment Outcome